GS
Gopalakrishna Sreemushanam Anandarao
About Gopalakrishna Sreemushanam Anandarao
Data last updated:
Gopalakrishna Sreemushanam Anandarao is a Director at Icrest Biotechnologies Limited (since 2008). The companies operate in Healthcare and Life Sciences. Icrest Biotechnologies Limited reported revenue of ₹1.68 Cr (FY 2025). Earlier, Gopalakrishna Sreemushanam Anandarao was a Director at Sri Raghavendra Biotechnologies Private Limited (2002–2022) and Managing Director at Cryo Stemcell Private Limited (2004–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Sep 2008 | 2008 | ₹1.68 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Nov 2002 | 2000 | ₹5 Lakh (FY 2025) | Active | |
| Managing Director | 07 Jun 2004 | 2003 | ₹1.11 Cr (FY 2018) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gopalakrishna Sreemushanam Anandarao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Basavalinga Ajaikumar Sadasivaiah | 00713779 | Icrest Biotechnologies Limited | Director |
| Gururaj Ananda Rao | 01902753 | Icrest Biotechnologies Limited | Managing Director |
| Jyothsna Ananda Rao | 01197460 | Icrest Biotechnologies Limited | Whole-Time Director |
| Sunanda Ananda Rao | 01197386 | Icrest Biotechnologies Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopalakrishna Sreemushanam Anandarao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopalakrishna Sreemushanam Anandarao
Gopalakrishna Sreemushanam Anandarao currently holds 1 directorship: Icrest Biotechnologies Limited (Director, since 17 Sep 2008, revenue ₹1.68 Cr (FY 2025)).
Gopalakrishna Sreemushanam Anandarao was first appointed on 07 Nov 2002 as Director at Sri Raghavendra Biotechnologies Private Limited. The most recent appointment on record is 17 Sep 2008 at Icrest Biotechnologies Limited.
Gopalakrishna Sreemushanam Anandarao held 2 earlier board appointments: Sri Raghavendra Biotechnologies Private Limited (Director, 07 Nov 2002 to 06 Dec 2022); Cryo Stemcell Private Limited (Managing Director, 07 Jun 2004 to 06 Mar 2010).
The current boards of Gopalakrishna Sreemushanam Anandarao's companies include Basavalinga Ajaikumar Sadasivaiah (Icrest Biotechnologies Limited), Gururaj Ananda Rao (Icrest Biotechnologies Limited), Jyothsna Ananda Rao (Icrest Biotechnologies Limited), Sunanda Ananda Rao (Icrest Biotechnologies Limited).